Filing Details
- Accession Number:
- 0001179110-12-002000
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-07 18:15:15
- Reporting Period:
- 2012-02-03
- Filing Date:
- 2012-02-07
- Accepted Time:
- 2012-02-07 18:15:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1391823 | L Edward Michael | 100 Abbott Park Road Abbott Park IL 60064-6400 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares Without Par Value | Acquisiton | 2012-02-03 | 51,311 | $53.63 | 258,761 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Disposition | 2012-02-03 | 42,511 | $55.00 | 216,250 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2012-02-03 | 200 | $55.01 | 216,050 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2012-02-03 | 4,800 | $55.01 | 211,250 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2012-02-03 | 100 | $55.01 | 211,150 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2012-02-03 | 1,500 | $55.02 | 209,650 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2012-02-03 | 2,200 | $55.02 | 207,450 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Acquisiton | 2012-02-06 | 1,890 | $53.63 | 209,340 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Disposition | 2012-02-06 | 1,842 | $55.00 | 207,498 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Option (right to buy) | Disposition | 2012-02-03 | 51,311 | $0.00 | 51,311 | $53.63 |
| Common Shares | Option (right to buy) | Disposition | 2012-02-06 | 1,890 | $0.00 | 1,890 | $53.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2005-02-15 | 2012-02-14 | No | 4 | M | Direct |
| 0 | 2005-02-15 | 2012-02-14 | No | 4 | M | Direct |
Footnotes
- Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.
Billionaire Hedge Funds
